Delivery Order SPE2DB22D3011-SPE2DB25FP8WN

Award Date 1/23/25
Potential Completion Date 1/24/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,246.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CLINDAMYCIN 600 MG/50 ML-D5W 50ML, a medical product, with a completion date of January 30, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,289.34 firm fixed-price delivery order contract is for the supply of Clindamycin 900 mg/50 ml-D5W 50 ml, a medication used to treat various bacterial infections. The contract has an ultimate completion date of November 8, 2024 and was awarded on November 7, 2024. This award is associated with a larger...
This federal contract award, valued at $1,684.59, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4565158696 - CLINDAMYCIN 60ML 1S, a pharmaceutical product. The contract has a completion date of July 17, 2024 and is a Firm Fixed Price Delivery Order. This award is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of a specific pharmaceutical product - Clindamycin 900 mg/50 ml-D5W 50 ml. The contract has a firm fixed price of $3,734.82 and a period of performance through June 13, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,359.13 firm fixed price delivery order is for the supply of 4568513111 - CLINDAMYCIN 150MG 100S, a pharmaceutical product. The contract has an ultimate completion date of July 10, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of Clindamycin 900 mg/50 ml-D5W 50 ml, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $27,286.19 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on January 23, 2024, with a completion date of January 24, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,398.72 firm fixed price contract is for the supply of 4565357729 ! CLINDAMYCIN 600 MG/50 ML-D5W 50ML, with a completion date of August 7, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to...
This federal contract award, valued at $1,714.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, is a firm fixed price Delivery Order from the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $5,485.33, is for the supply of 4,564,097,716 units of Clindamycin 900 mg/50 mL-D5W 50 mL. The contract has a performance period through March 28, 2024 and does not utilize any set-aside designations. The award is associated with a larger indefinite delivery...
This federal contract award is for the delivery of CLINDAMYCIN QS 100ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,898.28 and an ultimate completion date of June 20, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. This contract is not set-aside and was awarded on May 22, 2025....
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB25FP8WN
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order with a firm fixed price of $1,544.32. The contract is for the supply of Clindamycin 900 mg/50 ml-D5W 50 ml, a pharmaceutical product, to support Defense Logistics Agency (DLA) Troop Support Medical programs. The contract has an ultimate completion date of January 24, 2025 and was awarded on January 23, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999 and running through November 2026, which provides a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/24/25, 11:21 AM